PegBio Co., Ltd. (HKG:2565)

PegBio Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2020	FY 2019
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	375.62	467.54	28.39	77.15	773.13	33.77
Trading Asset Securities	33.07	54.47	153.66	263.08	84.57	23.37
Cash & Short-Term Investments	408.69	522.01	182.05	340.23	857.7	57.14
Cash Growth	22.84%	186.75%	-46.49%	-60.33%	1401.02%	24.25%
Other Receivables	0.57	0.71	3.36	0.05	0.01	-
Receivables	0.57	0.71	3.36	0.05	0.01	-
Inventory	3.05	0.87	-	-	5.35	11.48
Other Current Assets	44.87	32.69	4.89	5.2	25.59	7.49
Total Current Assets	457.18	556.28	190.29	345.48	888.66	76.11
Property, Plant & Equipment	12.73	15.27	5.1	6.95	3.09	3.45
Other Intangible Assets	0.38	0.55	0.86	0.98	0.17	0.24
Long-Term Deferred Charges	-	-	-	-	3.32	4.57
Other Long-Term Assets	33.98	27.13	22.1	14.65	15.07	9.15
Total Assets	504.27	599.23	218.36	368.05	910.32	93.52

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2020	FY 2019
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2020	Dec 31, 2019
Accounts Payable	24.5	25.24	35.12	90.61	23.48	67.78
Accrued Expenses	4.79	24.91	3.96	6.34	5.45	2.26
Short-Term Debt	145	84.97	100	65.78	110.14	35.05
Current Portion of Leases	1.86	2.05	1.27	1.42	-	-
Current Income Taxes Payable	0.69	0.95	0.43	0.81	-	-
Other Current Liabilities	1.81	2.94	16.88	0.03	1.19	79.09
Total Current Liabilities	178.66	141.06	157.67	164.99	140.27	184.18
Long-Term Leases	5.77	6.59	0.22	1.71	-	-
Long-Term Unearned Revenue	3	3	3	6	15.65	15.76
Total Liabilities	237.43	150.64	160.89	172.7	155.92	199.94

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2020	FY 2019
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2020	Dec 31, 2019
Common Stock	391.09	391.09	366.67	366.67	354.51	254.22
Additional Paid-In Capital	-	-	-	-	445.91	166.8
Retained Earnings	-	-1,343	-1,134	-851.1	-52.3	-534.94
Comprehensive Income & Other	-124.3	1,400	819.77	674.31	-	-
Total Common Equity	266.79	448.49	52.19	189.88	748.12	-113.92
Minority Interest	0.05	0.1	5.28	5.47	6.28	7.5
Shareholders' Equity	266.84	448.59	57.47	195.35	754.39	-106.42
Total Liabilities & Equity	504.27	599.23	218.36	368.05	910.32	93.52

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2020	FY 2019
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2020	Dec 31, 2019
Total Debt	152.63	93.61	101.49	68.91	110.14	35.05
Net Cash (Debt)	256.06	428.41	80.55	271.32	747.56	22.09
Net Cash Growth	2.96%	431.83%	-70.31%	-63.71%	3284.57%	5.23%
Net Cash Per Share	0.66	1.13	0.22	0.75	2.81	-
Filing Date Shares Outstanding	391.09	391.09	385.96	361.61	354.51	-
Total Common Shares Outstanding	391.09	391.09	366.67	361.61	354.51	-
Working Capital	278.52	415.23	32.63	180.49	748.39	-108.07
Book Value Per Share	0.68	1.15	0.14	0.53	2.11	-
Tangible Book Value	266.42	447.93	51.33	188.91	747.94	-114.16
Tangible Book Value Per Share	0.68	1.15	0.14	0.52	2.11	-
Machinery	-	12.42	12.41	12.32	8.71	8.22
Leasehold Improvements	-	10.41	6.24	6.24	-	-

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 27, 2026

Data Sources Report a data error